Literature DB >> 1881550

Magnetic resonance imaging in familial central diabetes insipidus.

S Miyamoto1, N Sasaki, Y Tanabe.   

Abstract

More detailed examinations of the pituitary gland in central diabetes insipidus (CDI) has been possible with magnetic resonance imaging (MRI). Compared to the high signal findings in the posterior lobes of normal subjects, the absence of such signal in adults and children with primary CDI has been reported. Familial CDI is a hereditary form of primary CDI with a variety of clinical expressions among affected individuals which is said to be related to varying degrees of an arginine vasopressin (AVP) deficiency. However, the structural correlates have yet to be documented by MRI technique. This report describes the pituitary gland MRI findings (using a superconducting magnet; 3 mm-slice thickness; spinecho, repetition time 400 ms, echo time 25 ms) in five patients in one family with familial CDI. A signal of high intensity was detected in the posterior part of the pituitary gland in 2 patients but not in 3 others. We concluded that MRI of the posterior pituitary lobe in familial CDI seem to vary in members of the same family.

Entities:  

Mesh:

Year:  1991        PMID: 1881550     DOI: 10.1007/bf00588235

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

1.  HEREDITARY IDIOPATHIC DIABETES INSIPIDUS. A CASE REPORT WITH AUTOPSY FINDINGS.

Authors:  L E BRAVERMAN; J P MANCINI; D M MCGOLDRICK
Journal:  Ann Intern Med       Date:  1965-09       Impact factor: 25.391

2.  Posterior lobe of the pituitary in diabetes insipidus: MR findings.

Authors:  I Fujisawa; K Nishimura; R Asato; K Togashi; K Itoh; S Noma; Y Kawamura; T Sago; S Minami; Y Nakano
Journal:  J Comput Assist Tomogr       Date:  1987 Mar-Apr       Impact factor: 1.826

3.  Recognition of partial defects in antidiuretic hormone secretion.

Authors:  M Miller; T Dalakos; A M Moses; H Fellerman; D H Streeten
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

4.  MR imaging of the posterior hypophysis in children.

Authors:  F Gudinchet; F Brunelle; M O Barth; V Taviere; R Brauner; R Rappaport; D Lallemand
Journal:  AJR Am J Roentgenol       Date:  1989-08       Impact factor: 3.959

5.  Vasopressin function in familial cranial diabetes insipidus.

Authors:  P H Baylis; G L Robertson
Journal:  Postgrad Med J       Date:  1981-01       Impact factor: 2.401

6.  Anterior and posterior lobes of the pituitary gland: assessment by 1.5 T MR imaging.

Authors:  I Fujisawa; R Asato; K Nishimura; K Togashi; K Itoh; Y Nakano; H Itoh; N Hashimoto; J Takeuchi; K Torizuka
Journal:  J Comput Assist Tomogr       Date:  1987 Mar-Apr       Impact factor: 1.826

7.  1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.

Authors:  D J Becker; T P Foley
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

8.  Radioimmunoassay of vasopressin in familial cental diabetes insipidus.

Authors:  P B Kaplowitz; A J D'Ercole; G L Robertson
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

  8 in total
  3 in total

1.  Diabetes insipidus in pediatric germinomas of the suprasellar region: characteristic features and significance of the pituitary bright spot.

Authors:  John-Paul Kilday; Suzanne Laughlin; Stacey Urbach; Eric Bouffet; Ute Bartels
Journal:  J Neurooncol       Date:  2014-09-30       Impact factor: 4.130

2.  A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

Authors:  Camilla Birkegaard; Jane H Christensen; Alberto Falorni; Stefania Marzotti; Viviana Minarelli; Niels Gregersen; Søren Rittig
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

3.  Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.

Authors:  S Schmitt; W Wichmann; E Martin; M Zachmann; E J Schoenle
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.